|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,803.30 INR | -0.29% |
|
+3.78% | -18.43% |
| 08/07 | Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025 | |
| 02/07 | Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited | CI |
| Capitalization | 19TCr 219.87Cr 188.01Cr 175.13Cr 162.88Cr 300.96Cr 334.47Cr 2.1TCr 802.31Cr 8.83TCr 824.63Cr 807.63Cr 32TCr | P/E ratio 2025 |
47.3x | P/E ratio 2026 * | 41.1x |
|---|---|---|---|---|---|
| Enterprise value | 18TCr 214.28Cr 183.23Cr 170.68Cr 158.75Cr 293.32Cr 325.97Cr 2.05TCr 781.92Cr 8.61TCr 803.67Cr 787.11Cr 32TCr | EV / Sales 2025 |
14.4x | EV / Sales 2026 * | 12.9x |
| Free-Float |
24.94% | Yield 2025 |
0.64% | Yield 2026 * | 0.57% |
More valuation ratios
* Estimated data
More news
Last Transcript: Concord Biotech Limited
More recommendations
| 1 day | -0.29% | ||
| 1 week | +3.78% | ||
| Current month | -1.97% | ||
| 1 month | -12.61% | ||
| 3 months | +9.04% | ||
| 6 months | -20.08% | ||
| Current year | -18.43% |
| 1 week | 1,721 |  | 1,874.7 |
| 1 month | 1,721 | | 2,146 |
| Current year | 1,345 | | 2,451.7 |
| 1 year | 1,345 | | 2,664 |
| 3 years | 900.05 | | 2,664 |
| 5 years | 900.05 | | 2,664 |
| 10 years | 900.05 | | 2,664 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sudhir Vaid
CEO | Chief Executive Officer | 72 | 10/05/2000 |
| Chief Executive Officer | - | 01/09/2011 | |
Lalit Sethi
DFI | Director of Finance/CFO | 59 | 14/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 30/06/2008 | |
| Director/Board Member | 65 | 24/05/2022 | |
| Director/Board Member | 80 | 31/01/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.29% | +3.78% | +6.71% | - | 219.87Cr | ||
| -0.61% | -0.76% | -21.42% | -17.69% | 7.67TCr | ||
| +1.43% | +3.72% | -48.39% | -6.94% | 6TCr | ||
| -2.13% | +5.70% | +28.43% | +26.74% | 5.47TCr | ||
| -0.96% | +1.21% | +18.84% | +101.21% | 3.8TCr | ||
| -0.83% | +1.01% | -41.66% | -37.74% | 1.97TCr | ||
| +0.37% | -6.55% | +97.91% | +124.37% | 1.75TCr | ||
| -2.23% | +16.91% | +61.10% | +753.81% | 1.71TCr | ||
| -0.04% | -.--% | +68.78% | +142.10% | 1.4TCr | ||
| -2.49% | +0.20% | +7.74% | -14.71% | 1.33TCr | ||
| Average | -0.78% | +1.27% | +17.80% | +119.02% | 3.13TCr | |
| Weighted average by Cap. | -0.63% | +1.17% | +2.39% | +63.14% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 1.17TCr 14Cr 12Cr 11Cr 10Cr 19Cr 21Cr 130.04Cr 50Cr 547.4Cr 51Cr 50Cr 2.01TCr | 1.44TCr 17Cr 14Cr 13Cr 12Cr 23Cr 25Cr 159.66Cr 61Cr 672.08Cr 63Cr 61Cr 2.47TCr |
| Net income | 353.7Cr 4.12Cr 3.52Cr 3.28Cr 3.05Cr 5.64Cr 6.27Cr 39Cr 15Cr 165.61Cr 15Cr 15Cr 607.45Cr | 457.69Cr 5.33Cr 4.56Cr 4.25Cr 3.95Cr 7.3Cr 8.11Cr 51Cr 19Cr 214.3Cr 20Cr 20Cr 786.05Cr |
| Net Debt | -479.4Cr -5.59Cr -4.78Cr -4.45Cr -4.14Cr -7.65Cr -8.5Cr -53Cr -20Cr -224.46Cr -21Cr -21Cr -823.34Cr | -372.6Cr -4.34Cr -3.71Cr -3.46Cr -3.22Cr -5.94Cr -6.61Cr -41Cr -16Cr -174.46Cr -16Cr -16Cr -639.92Cr |
More financial data
* Estimated data
Employees
1,377
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/25/11 | 1,803.30 ₹ | -0.29% | 1,24,823 |
| 10/25/10 | 1,808.50 ₹ | -0.63% | 1,14,068 |
| 09/25/09 | 1,819.90 ₹ | +1.50% | 4,10,373 |
| 08/25/08 | 1,793.00 ₹ | +1.83% | 2,98,425 |
| 07/25/07 | 1,760.80 ₹ | +1.33% | 2,84,360 |
Delayed Quote NSE India S.E., July 11, 2025 at 05:19 pm IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,803.30INR
Average target price
1,937.00INR
Spread / Average Target
+7.41%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CONCORDBIO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition